Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Antitumor and Cytogenotoxic Activities of Libidibia ferrea Hydroalcoholic Extracts in Murine Breast Carcinoma

View through CrossRef
ABSTRACTBreast cancer is the most prevalent cancer type among women worldwide, and there is a critical need for more effective and safer treatments, especially for aggressive and therapy‐resistant subtypes. Libidibia ferrea, a native plant from Brazil, exhibits anti‐inflammatory, antimicrobial, antioxidant, and antitumor properties. This study evaluated the antioxidant activity and antitumor effects of hydroalcoholic extracts from the leaves (HAFL) and fruits (HAFR) of L. ferrea in murine breast carcinoma models. Chemical analysis revealed several phenolic compounds, including gallic and ellagic acids. HAFR showed three times more total phenolic content than HAFL and exhibited higher antioxidant, cytotoxic, and genotoxic activities, inducing DNA damage and cell death in MDA‐MB‐231 cells. In a 4T1 murine model, HAFR reduced tumor growth by 94% at doses of 0.3 and 3.0 g/kg without affecting body or liver weight. These findings suggest HAFR's potential as a therapeutic candidate for breast cancer treatment.
Title: Antitumor and Cytogenotoxic Activities of Libidibia ferrea Hydroalcoholic Extracts in Murine Breast Carcinoma
Description:
ABSTRACTBreast cancer is the most prevalent cancer type among women worldwide, and there is a critical need for more effective and safer treatments, especially for aggressive and therapy‐resistant subtypes.
Libidibia ferrea, a native plant from Brazil, exhibits anti‐inflammatory, antimicrobial, antioxidant, and antitumor properties.
This study evaluated the antioxidant activity and antitumor effects of hydroalcoholic extracts from the leaves (HAFL) and fruits (HAFR) of L.
ferrea in murine breast carcinoma models.
Chemical analysis revealed several phenolic compounds, including gallic and ellagic acids.
HAFR showed three times more total phenolic content than HAFL and exhibited higher antioxidant, cytotoxic, and genotoxic activities, inducing DNA damage and cell death in MDA‐MB‐231 cells.
In a 4T1 murine model, HAFR reduced tumor growth by 94% at doses of 0.
3 and 3.
0 g/kg without affecting body or liver weight.
These findings suggest HAFR's potential as a therapeutic candidate for breast cancer treatment.

Related Results

Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Antitumor Immunity and Therapeutic Properties of Marine Seaweeds-derived Extracts in The Treatment of Cancer
Antitumor Immunity and Therapeutic Properties of Marine Seaweeds-derived Extracts in The Treatment of Cancer
Abstract Marine seaweeds are important sources of drugs with several pharmacological characteristics.The present study aims to evaluate the antitumor and antitumor immunolo...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
THU504 Is Carney Complex A Predisposing Syndrome For Breast Cancer? Prospective Study Of 50 Women
THU504 Is Carney Complex A Predisposing Syndrome For Breast Cancer? Prospective Study Of 50 Women
Abstract Disclosure: P. Vaduva: None. F. Violon: None. A. Jouinot: None. L. Bouys: None. S. Espiard: None. F. Bonnet-Serrano: None. N. Marie Odile: None. C. Cardot-b...

Back to Top